Hybridoma 2E3-O cells were transfected with bcl-2 alone or with bcl-2 and bag-1 in combination. The bcl-2/bag-1 transfectant survived maintaining viability above 75% for almost 5 days when the cells were treated with excess (30 mM) thymidine for arresting cell cycle, whereas the mock transfectant survived for only 2 days, and the bcl-2 alone transfectant lived for 4 days. Owing to this extended viable culture period, the bcl-2/bag-1 transfectant produced twofold amount of antibody in comparison with the mock transfectant in non-proliferating state prepared by the excess thymidine treatment. When their proliferation was arrested by serum limitation, the bcl-2/bag-1 transfectant and the bcl-2 alone transfectant survived for 3 days maintaining viability above 75% while the mock transfectant survived only 1 day. The bcl-2/bag-1 transfectans produced the antibody at the rate three times as high as the bcl-2 alone transfectant and the mock transfectant in non-proliferating state established by serum limitation. Such genetic engineering of hybridoma cells for improving survival in the non-proliferating state will be useful for using nutrients in culture medium efficiently to produce antibody, since nutrients could be diverted from cell proliferation to antibody production in such non-proliferating viable cell culture.
Introduction
Method of arresting the cell cycle of mammalian cells while maintaining them viably is useful for basic research and application in the field of cytotechnology. Arresting cell cycling of hybridoma cells often enhances their antibody productivity (Suzuki et al., 1992; Ramirez and Mutharasan, 1990) . Antibody synthesis rate was often larger at late G1 and S phases than at the other points of the cell cycle in many hybridoma or myeloma cell lines (Al-Reubeai et al., 1989; Buell et al., 1969; Byars and Kidson, 1970; Garatun-Yjeldst/o et al., 1971; Pryme, 1974; Takahashi et al., 1969) . mRNAs encoding antibodies are usually stable and hence accumulate in non-proliferating cells, resulting in increased antibody production rate (Takahashi et al., 1994) . In culture of non-proliferating viable hybridoma cells, resources in culture medium such as amino acids may be diverted to synthesis of antibody from that of cell components for cell growth (Suzuki and Ollis, 1990) .
Synchronous culture, which is prepared by cell cycle arrest at a specific point of the cell cycle followed by reinitiation of cell cycling, is useful for studying characteristics of each phase of the cell cycle. Culturing cells at high concentration of thymidine (Terashima and Tolmach, 1963) , or under serum limitation (Zetterburg and Larson, 1985) is a technique commonly used for arresting cell cycling. Any inhibitors of DNA synthesis arrest cells; those commonly used are inhibitors of the synthesis of deoxyribonucleotide triphosphates such as thymidine at high concentrations (Johnson et al., 1993) . Cells located outside S phase at the time of excess thymidine addition are arrested when they pass through the G1/S boundary. For preparing synchronous culture, a double thymidine treatment, in which cells are arrested anywhere in S by giving excess thymidine, released by eliminating thymidine, and arrested again by giving excess thymidine when the population has moved out of S, is iseful in order to accumulate cells close to the G1/S boundary (Stein and Borun, 1972) . The cells accumulated at G1/S boundary are released from arrest by culturing at reduced thymidine concentration, and then synchronously progress in the cell cycle. However, prolonged or double treatment with excess thymidine can be toxic to some cell lines. For example, hybridoma cells are not sturdy enough to maintain high viability during thymidine treatment. Hence, the excess thymidiner method can not be applied for establishinh arrested or synchronous culture of hybridoma cells.
Serum deprivation arrests cell cycle firstly at early G1 and then the arrested cells enter in G0 (Zetterburg anf Larson, 1985) . However, it induces apoptosis, suicidal cell death, of many kinds of cells including hybridoma cells (Singh et al., 1994; Mercille and Massie, 1994) . No practical methods of establishing viably arrested culture of hybridoma cells have been developed. Our experience of applying various methods of growth-suppression to hybridoma cells suggested that suppression of hybridoma proliferation usually induces apoptosis. Therefore, in this work, we tried to engineer hybridoma cells by using apoptosis suppressing genes, bcl-2 and bag-1, to make them resistant to apoptosis and durable in the excess thymidine treatment and the low serum culture.
bcl-2 is a gene known to suppress multiple forms of apoptosis (Pattersson et al., 1992; Reed 1994) . High level expression of human bcl-2 protein resulted in the better survival of mouse myeloid cells in the absence of the growth factor (Tsujimoto, 1989) and lymphokine (Vaux et al., 1988) . Deregulated bcl-2 expression prolonged survival of growth factor-deprived hemopoietic cell lines (Nunez et al., 1990) . The high levels of the bcl-2 gene product protected human B cells from a variety of agents giving stress including heat shock, ethanol, DNA-damaging agents, and serum deprivation (Tsujimoto, 1989; Miyashita and Reed 1992) .
Recently, BAG-1, Bcl-2 association athagogene 1, protein was discovered (Takayama et al., 1995) . Coexpression of bag-1 and bcl-2 can provide markedly increased protection from cell death induced by several stimuli. In addition, BAG-1 binds to Hsp 70/Hsc70 family proteins, modulating their activities, and providing protection against apoptosis and cellular stress (Takayama et al., 1997) .
Cell engineering using these apoptosis suppressing genes enabled hybridoma cells to survive longer in non-proliferating state induced by excess thymidine treatment or by serum limitation.
Materials and methods

Cell line and culture condition
The cell line 2E3-O employed throughout this study is a mouse hybridoma derived from a mouse myeloma P3X63 AG8U.1 by electric fusion with mouse spleen cells (Makishima et al., 1992) .
The hybridoma is a high producer of an IgG 1 specific to a trinitrophenyl(TNP)-hapten. The cells were cultured in DME medium (Nissui, Tokyo), supplemented with 10% vol/vol FBS (JRH Bioscience, lot. 4C2042), 20 mM HEPES, 0.2% NaHCO 3 , 2 mM glutamine, and 0.06 mg ml 1 kanamycin. The cells were grown in 24 well plate (Iwaki glass) at 37 C in humidified air containing CO 2 at 5%.
Transfection
The vector BCMGneo-bcl-2 for expressing human bcl-2 (Tsujimoto, 1989) in the hybridoma cells was prepared as reported elsewhere (Itoh et al., 1995) . The expression vector pZeo-bag-1 was prepared by insering murine bag-1 cDNA (Takayama et al., 1995) into pZeoSV vector (Invitrogen). Hybridoma 2E3-O was transfected with BCMGSneo vector (Karasuyama et al., 1990) , with BCMGneo-bcl-2 and pZeo vectors, and with BCMGneo-bcl-2 and pZeo-bag-1 vectors, respectively, and named mock transfectant 2E3O-mock, bcl-2 transfectant 2E3O-bcl-2, and bcl-2/bag-1 transfectant 2E3O-bcl-2/bag-1. The transfection method was electroporation. For selecting successfully transfected cells, 2E3O-mock was cultured in the presence of H418 (Gibco) at 0.25 mg ml 1 , and 2E3O-bcl-2 and 2E30-bcl-2/bag-1 were cultured in the presence of 0.25 mg ml 1 G418 (Gibco) and 0.25 mg ml 1 Zeocin (Invitrogen). Viable and dead cells were determined by counting in a hemocytometer under a phase contrast microscope using trypan blue exclusion. All experiments were performed in duplicate or triplicate. 
Cell cycle arrest by excess thymidine
Exponentially growing cells are harvested from cultures by centrifugation, and resuspended in the standard culture medium supplemented with thymidine (Wako Junyaku, Osaka) at various concentrations. 
Cell cycle arrest by serum limitation
Exponentially growing cells were harvested from cultures by centrifugation, washed twice with DME medium, and resuspended in the standard culture medium supplemented with FBS at a concentration of 0.2% instead of 10%.
Determination of antibody concentration
The antibody concentration was determined by ELISA (Engvall, 1980) . The antibody produced by 2E3-O cells was sandwiched by rabbit anti-mouse IgG polyclonal antibody (ZYMED Laboratories) and peroxidase-conjugated goat anti-mouse Ig polyclonal antibody (bio Source International, Inc.-Tago Products). Amount of the antibody was determined by measuring absorbance, using o-phenylenediamine dihydrochloride as substrate for the peroxidase. A known amount of the purified antibody secreted by 2E3-O cells was used as standard.
Results and discussion
Bcl-2 anf bcl-2/bag-1 transfectants survived longer when arrested with excess thymidine
Hybridoma 2E3-O cells expressing bcl-2 alone (2E3/-bcl-2), those coexpressing bcl-2 and bag-1 (2E3O-bcl-2/bag-1), and those transfected with vector BCMGSneo alone (mock transfectant 2E3O-mock) were prepared as described in Materials and Methods. The expression of bcl-2 and bag-1 proteins was confirmed by western blot using anti-human Bcl-2 antibody and anti-mouse BAG-1antibody, respectively (data not shown). These transfectants were cultured with 0, 10 or 30 mM thymidine in the culture medium described in Methods and Materials. Figure 1-A, B , and C show the growth curves of the mock, the bcl-2 alone, and the bcl-2/bag-1 double transfectants, respectively. Proliferation of all the three transfectants was similarly suppressed by thymidine in dose dependent manner, being completely suppressed at 30 mM of thymidine. The cell cycle turned round two to three times initially, before thymidine at 10 mM completely suppressed proliferation of all the three transfectants. the hybridoma cells during excess thymidine treatment will make the preparation of synchronous culture using the double thymidine treatment more successful.
Bcl-2 and bcl-2/bag-1 transfectants survived longer when arrested by serum limitation
The bcl-2 transfectant, the bcl-2/bag-1 cotransfectant, and the mock transfectant were cultured at various concentrations of fetal bovine serum (FBS). All three transfectants ceased proliferating when the FBS concentration was reduced to 0.2% (vol/vol). ly, of the three transfectants cultured with 0.2% FBS. The bcl-2 transfection improved survival of the nonproliferating hybridoma cells under serum limitation, prolonging the viable culture period maintaining viability above 75% from 1 day to 4 days. Cotransfection of bag-1 which bcl-2 did not further improve the survival in comparison with the bcl-2 alone transfection.
Bcl-2 and bcl-2/bag-1 transfectants produced more antibody when arrested with excess thymidine
Antibody concentrations in the culture supernatant of the three transfectants cultured with excess thymidine at 30 mM are shown in Figure 3 . The bcl-2/bag-1 cotransfectant produced twofold more antibody in comparison with the mock transfectants. This increased production was due to the prolonged viable culture period, but not to the increased antibody production rate of single cell as discussed below. Figure 4 shows the specific antibody production rate, antibody production rate per viable cell, of the three transfectants cultured with thymidine at 0, 10, and 30 mM. The rate was calculated as the amount of the antibody produced between 66 h and 137 h of the cultures devided by the viable cell number integrated with respect to time in the interval. The specific poduction rate of the mock transfectant increased and the growth rate decreased as thymidine concentration was raised. This nagative correlation between the antibody production rate and the growth rate is consistent with the reported data (Suzuki and Ollis, 1990; Takahashi et al., 1994) . However, the specific antibody production rate of the bcl-2 transfectant and the bcl-2/bag-1 contransfectant did not increase with decreasing growth rate. In other words, both the exponentially growing and the non-growing bcl-2 or bcl-2/bag-1 transfectants produced antibody at the similar rates in these cases. This different correlation between the specific antibody production rate and the growth rate can be a clue for studying anti-apoptotic mechanism involving bcl-2 and bag-1 proteins. For example, it may suggest that under the excess thymidine condition bcl-2 protein suppresses synthesis of mRNSA which are unnecessary to survival.
Bcl-2/bag-1 contransfectant produced antibody at threefold rate when arrested with serum limitation Figure 5 shows the specific antibody production rate of the three transfectants completely arrested as shown in Figure by culturing in the medium supplemented with ABS at 0.2% instead of standard 10%. While the three transfectants and the untransfected 2E3-/O (data not shown) produced the antibody at the rate of 10 pg cell 1 d 1 in proliferating state (data at 0 mM thymi-dine in Figure 4 ), all the three transfectants did at the increased rate of 20 to 30 pg cell 1 d 1 in the nonproliferating state. This increase in antibody production rate associated with suppression of proliferation is consistent with the reported data (Suzuki and Ollis, 1990; Takahashi et al., 1994) and with the data for the mock transfectant arrested by 10 or 30 mM thymidine shown in Figure 4 . It is noticeable that among the three transfectants, the bcl-2/bag-1 contransfectant produced the anitbody at the highest rate and maintained the high rate through the culture, while the other transfectants lost their enhanced productivity rapidly. The reason of this synergetic effect of bcl-2/bag-1 contrasfection is unknown because how bcl-2 blocks apoptosis is not elucidated. But recently two protein that bind to BAG-1 were reported (Bardelli et al., 1996; Wang et al., 1996) . One is Raf-1 and another is gepatocyte growth factor receptor. Raf-1 is major member in nitogen-activated protein kinase (MARK) cascade. It is well-known that the MARK cascade plays a crucial role in the transduction of extracellular signals into responses governing growth and differentiation. Thus BAG-1 associates with a certain regulating factor such as Raf-1 and might regulate protein synthesis or cell differentiation.
The culture of the bcl-2/bag-1 cotransfectant produced the antibody fourfold in total owing to the longer maintained high specific production rate and high viability in comparison with the mock transfectants.
Conclusion
We genetically modified the hybridome 2E3-O cells by transfecting with anti-apoptic genes bcl-2 and bag-1 so that they can survive in non-proliferating state prepared by excess thymidine treatment or by serum limitation. Such genetic engineering of hybridome cells will be applied for keeping the cells viable during double thymidine treatment to establish synchronous culture for cell cysle analysis.
Using these apoptosis-resistant hybridoma cells, non-proliferating viable hybridoma cell culture can be established by applying excess thymisine treatment or serum limitation. In such non-proliferating viable cell culture, the hydridoma cells can utilize nutrients in medium efficiently for antibody production by diverting them from cell growth to antibody production.
